NCT07123701View on ClinicalTrials.gov

Clinical Study of Tanshinone Capsules Against COVID-19

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

July 1, 2025

Study Completion Date

July 1, 2025

Conditions
COVID-19 (Coronavirus Disease 2019)
Interventions
DRUG

Tanshinone capsules

Tanshinone capsules were used in this intervention for COVID-19 patients

Trial Locations (1)

523000

Dongguan People's Hospital, Dongguan

All Listed Sponsors
lead

Liu Shuwen

OTHER

NCT07123701 - Clinical Study of Tanshinone Capsules Against COVID-19 | Biotech Hunter | Biotech Hunter